Desmethylclozapine
Small moleculeexperimental
N-Desmethylclozapine (NDMC), or norclozapine, is a major active metabolite of the atypical antipsychotic drug clozapine. — Wikipedia
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 30, 2017 (NCT03375034)
Timeline
Indications
Studied for
Mechanism of action
- Muscarinic acetylcholine receptor M1ACTIVATOR
CHRM1 activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaDesmethylclozapine ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04480164 | Phase 2 | Jun 24, 2020 | University of Geneva |
| NCT03375034 | Phase 1 | Mar 30, 2017 | University of Geneva |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Geneva | Academic/Hospital | 2 | 2 | 2 | 2017 |
1 organizations
Page 1 / 1